top of page

What’s new in the TB section of the 2023 WHO Model Lists of Essential Medicines

The World Health Organization’s (WHO’s) 2023 Model Lists of Essential Medicines, published in July 2023, features key updates to the tuberculosis (TB) section. These complement current WHO recommendations for shorter treatment of multidrug-/rifampicin-resistant TB (MDR/RR-TB) and newer options to treat drug-susceptible TB in children and adolescents. WHO’s Global Tuberculosis Programme, with inputs from partners, proposed these changes to the EML based on the latest WHO recommendations and the current availability of TB medicines. Read more here.

20 views0 comments

Recent Posts

See All

These diagnostic advances could be life-changing for the almost half-million people who develop DR-TB annually, but they have yet to reach the most needy patients. The task at hand is to support natio

bottom of page